Skip to main content
. Author manuscript; available in PMC: 2024 Jun 15.
Published in final edited form as: Biol Psychiatry. 2022 Nov 8;93(12):1099–1107. doi: 10.1016/j.biopsych.2022.10.018

Table 1.

Demographic and PET parameters for the study population

HC (n=18) BD-dep (n=17) BD-euth (n=10) MDD (n=17) Statistical test (F or Chi2, p)
Age, years (mean±SD) 36.4±12.8 38.9±11.9 36.6±13.0 33.2±12.1 0.605, 0.615
Sex (%female) 66.7 64.7 50.0 70.6 1.231, 0.746
Tobacco users (%) 22.2 23.5 50.0 29.4 2.790, 0.425
MADRS (mean±SD) 0.7±1.4** 19.0±6.1†† 4.6±3.3** 21.6±6.4†† 63.395, <0.001
Psychotropic medication (%taking medication) NA 23.5 30.0 26.7 0.139, 0.993
Injected tracer dose, MBq (mean±SD) 155.9±32.0 153.0±46.9 164.5±24.3 167.5±45.3 0.485, 0.694
Injected tracer mass, μg (mean±SD) 0.48±0.26 0.34±0.24 0.38±0.18 0.49±0.65 0.835, 0.443
Plasma free fraction, fP (mean±SD) 0.045±0.01 0.048±0.01 0.047±0.01 0.048±0.01 0.210, 0.889
Input function, 90–120 min. SUV (mean±SD) 0.178±0.03 0.166±0.05 0.157±0.03 0.150±0.04 1.301, 0.283
**

punadj<0.01 vs. MDD

††

punadj<0.01 vs. HC

Main effect of diagnosis, correcting for arterial vs. venous-derived input function